Performance analysis of BriaCell Therapeutics Corp - New (BCTX)
Annual Return
Over the past 3 years, BCTX has had an average annual return of -81.97%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, BCTX has had an average annual return of -61.37%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, BCTX has had an average annual return of -50.55%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Oct 28, 2010, BCTX has had an average annual return of -44.30%, underperforming the benchmark SPY, which returned +14.44% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -93.33% | -90.32% | +33.62% | -47.03% | +99.09% | -53.78% | -42.79% | -47.54% | -33.36% | -18.38% | +31.35% |
| 2014 | 2013 | 2012 | 2011 | 2010 | |||||||
| +115.53% | -57.86% | -68.60% | -63.27% | +5.95% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | |||||
| 2025 | -40.00% | -33.33% | +0% | +33.33% | -25.00% | -16.67% | -80.00% | +0% | +100% | +0% | +0% | -50.00% | -93.33% |
| 2024 | -29.68% | -16.51% | -16.48% | -25.00% | -21.05% | -33.33% | -33.33% | +5% | +57.14% | -36.36% | +23.81% | -42.31% | -90.32% |
| 2023 | +70.69% | -5.56% | +5.35% | +0% | -20.30% | +8.28% | +4.12% | +7.34% | -13.16% | -32.12% | +25% | +10.71% | +33.62% |
| 2022 | -23.74% | +20.96% | +32.67% | -31.34% | -28.26% | +15.91% | +12.42% | +19.19% | -27.32% | -2.68% | -2.07% | -18.31% | -47.03% |
| 2021 | +14.55% | -28.57% | +13.33% | -3.92% | -12.24% | +63.95% | -4.96% | +33.58% | +19.55% | -1.87% | +23.81% | -15.77% | +99.09% |
| 2020 | +103.78% | -4.54% | -56.16% | +3.94% | -9.48% | -32.98% | +48.44% | -21.58% | -23.49% | -5.26% | -9.26% | +12.24% | -53.78% |
| 2019 | +35.34% | +12.61% | +6.62% | -29.59% | +33.19% | -15.77% | -25.66% | -0.25% | -9.85% | -4.20% | -7.31% | -24.92% | -42.79% |
| 2018 | +5.04% | -23.89% | +37.54% | -18.12% | -0% | +33.89% | -17.05% | +0% | -0% | -20.05% | +1.26% | -35.20% | -47.54% |
| 2017 | -1.43% | +1.45% | +6.64% | -18.75% | +0% | +7.66% | -7.12% | +7.66% | -21.44% | -0% | +0% | -9.06% | -33.36% |
Drawdown analysis of BriaCell Therapeutics Corp - New (BCTX)
The maximum drawdown for the BCTX was -99.99%, occurring on Jul 15, 2025. This drawdown has not yet recovered.
The current BCTX drawdown is -99.99%.
Since Oct 28, 2010 BCTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 3 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | May 9, 2011 | 3468 | Jul 15, 2025 | Ongoing | Ongoing | Ongoing |
| -29.21% | Mar 4, 2011 | 7 | Mar 15, 2011 | 31 | Apr 28, 2011 | 38 |
| -27.53% | Oct 28, 2010 | 13 | Nov 16, 2010 | 20 | Dec 15, 2010 | 33 |